If a patient has a family history of MS, would you treat the patient with a TNF Blocker or switch to something else?

Featuring Benjamin Lockshin, MD | EVP of Strategic Initiatives Director of the Clinical Trials Center Assistant Professor US Dermatology Partners Georgetown University Rockville, MD | Published April 15, 2022